Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Reduce −2.2% | 17,041,811 | $19.76 | $337M | −376,857 | −$192M | |
| BHF - Brighthouse Finl | Reduce −4.0% | 3,637,688 | $51.66 | $188M | −150,000 | −$8M | |
| TECK - Teck Resources · CL B | Reduce −12.4% | 2,975,898 | $40.39 | $120M | −420,000 | +$22M | |
| Change Healthcare | Add +3.0% | 3,745,705 | $21.80 | $82M | +108,900 | +$4M | |
| Holding | Add +3.8% | 846,000 | $86.37 | $73M | +31,000 | −$4M | |
| GPN - Global Pmts | Hold | 506,000 | $136.84 | $69M | — | — | |
| CC - Chemours | Add +23.0% | 2,141,814 | $31.48 | $67M | +400,000 | +$9M | |
| ODP1 - The Odp | Reduce −2.3% | 1,405,090 | $45.83 | $64M | −32,500 | +$8M | |
| CEIXEUR - Consol Energy | Reduce −21.4% | 1,474,721 | $37.63 | $55M | −402,300 | +$13M | |
| Discovery | Add +153.4% | 1,652,000 | $24.92 | $41M | +1,000,000 | +$26M | |
| CPRI - Capri | Reduce −11.6% | 780,800 | $51.39 | $40M | −102,200 | −$17M | |
| REZI - Resideo Technologies | Add +29.4% | 1,513,383 | $23.83 | $36M | +344,000 | +$6M | |
| LIVN - Livanova | Add +29.0% | 440,000 | $81.83 | $36M | +99,000 | +$6M | |
| SLV - Ishares Silver Tr | Hold | 1,558,000 | $22.88 | $36M | — | — | |
| GLD - Spdr Gold Tr | Add +58.2% | 183,375 | $180.65 | $33M | +67,495 | +$13M | |
| KD - Kyndryl | Add +162.4% | 2,420,400 | $13.12 | $32M | +1,498,000 | +$15M | |
| Southwestern Energy | New | 4,133,000 | $7.17 | $30M | +4,133,000 | +$30M | |
| WFRD - Weatherford Intl | New | 703,500 | $33.30 | $23M | +703,500 | +$23M | |
| GPRO - Gopro · CL A | Reduce −8.0% | 2,697,200 | $8.53 | $23M | −234,700 | −$7M | |
| VSXY - Victorias Secret And | Reduce −4.1% | 436,081 | $51.36 | $22M | −18,800 | −$3M | |
| International Seaways | New | 1,023,000 | $18.04 | $18M | +1,023,000 | +$18M | |
| SNX - Td Synnex | New | 167,700 | $103.21 | $17M | +167,700 | +$17M | |
| PKG - Graphic Packaging | Hold | 832,270 | $20.04 | $17M | — | — | |
| CIVI - Civitas Resources | Add +135.3% | 278,218 | $59.71 | $17M | +160,000 | +$11M | |
| INTC - Intel | Hold | 309,500 | $49.56 | $15M | — | — | |
| PLBY Group | Add +100.0% | 820,000 | $13.09 | $11M | +410,000 | −$188K | |
| GPOR - Gulfport Energy | Add +6.7% | 113,136 | $89.82 | $10M | +7,082 | +$3M | |
| LKFT - Galapagos | Reduce −13.4% | 160,200 | $62.02 | $10M | −24,800 | −$263K | |
| NWSA - NEWS · CL B | Hold | 361,291 | $22.52 | $8M | — | — | |
| Neubase Therapeutics | Hold | 2,727,027 | $1.88 | $5M | — | — | |
| Danimer Scientific · CL A | Hold | 821,000 | $5.86 | $5M | — | — | |
| Playstudios · CLASS A | Hold | 963,018 | $4.85 | $5M | — | — | |
| CNX - Cnx Res | Hold | 222,715 | $20.72 | $5M | — | — | |
| ASTS - Ast Spacemobile · CL A | Reduce −25.0% | 427,500 | $9.98 | $4M | −142,500 | −$259K | |
| Waverley Capital Acquis | Hold | 350,000 | $9.79 | $3M | — | — | |
| Talis Biomedical | Add +42.5% | 2,235,783 | $1.41 | $3M | +666,483 | −$3M | |
| Finserv Acquisition Ii | Hold | 315,000 | $9.85 | $3M | — | — | |
| Panacea Acquisition Ii · CL A | Hold | 275,000 | $9.75 | $3M | — | — | |
| GANX - Gain Therapeutics | Hold | 546,560 | $4.09 | $2M | — | — | |
| XLE - Select Sector Spdr Tr | New | 14,700 | $76.39 | $1M | +14,700 | +$1M | |
| FCG - First Tr Exchange-Traded Fd | New | 34,000 | $24.38 | $829K | +34,000 | +$829K | |
| OIH - Vaneck ETF Trust | New | 2,900 | $282.76 | $820K | +2,900 | +$820K | |
| 23andme · CLASS A | Reduce −25.0% | 73,591 | $3.83 | $282K | −24,531 | −$371K | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $5.26 | $184K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2021 Q4
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Jack In The Box | Exit | 0 | $87.48 | $18M | −211,024 | −$18M | |
| SONO - Sonos | Exit | 0 | $29.80 | $13M | −438,680 | −$13M | |
| Exit | 0 | $43.22 | $11M | −243,750 | −$11M | ||
| CNXC - Concentrix | Exit | 0 | $178.61 | $10M | −54,436 | −$10M | |
| Freyr Battery | Exit | 0 | $11.18 | $4M | −350,000 | −$4M | |
| SATS - Echostar · CL A | Exit | 0 | $26.35 | $2M | −75,000 | −$2M | |
| FLNA - Cassava Sciences | Exit | 0 | $43.70 | $2M | −40,620 | −$2M | |
| Proterra | Exit | 0 | $8.83 | $133K | −15,070 | −$133K | |
| Astra Space · CL A | Exit | 0 | $6.25 | $8K | −1,279 | −$8K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2